Azithromycin versus ceftriaxone for the treatment of uncomplicated typhoid fever in children
R W Frenck1, I Nakhla, Y Sultan
1US Naval Medical Research Unit #3, Cairo, Egypt. FrenckR@namru3.med.navy.mil
Insights
Azithromycin and ceftriaxone are effective treatments for uncomplicated typhoid fever in children. Azithromycin offers a convenient oral alternative, particularly for resource-limited settings.
Area of Science:
- Pediatric Infectious Diseases
- Antimicrobial Therapy
Background:
- Typhoid fever remains a significant public health concern, particularly in developing countries.
- Effective and convenient treatment options for pediatric typhoid fever are crucial.
Purpose of the Study:
- To compare the efficacy of oral azithromycin versus intravenous ceftriaxone for treating uncomplicated typhoid fever in children.
- To evaluate azithromycin as a potential alternative treatment for pediatric typhoid fever.
Main Methods:
- A randomized trial involving 108 children aged 4-17 years with uncomplicated typhoid fever.
- Participants received either azithromycin (10 mg/kg/day) or ceftriaxone (75 mg/kg/day) for 7 days.
- Salmonella typhi isolates were tested for susceptibility to both antibiotics.
Main Results:
- High cure rates were observed for both azithromycin (91%) and ceftriaxone (97%) groups, with no statistically significant difference (P>.05).
- All Salmonella typhi isolates were susceptible to both azithromycin and ceftriaxone.
- Four patients in the ceftriaxone group experienced relapse; no serious side effects were reported for either treatment.
Conclusions:
- Oral azithromycin is an effective and well-tolerated treatment for uncomplicated typhoid fever in children.
- Azithromycin presents a promising, convenient alternative to ceftriaxone, especially in areas with limited medical resources.
Abstract:
A total of 108 children aged 4-17 years were randomized to receive 7 days of azithromycin (10 mg/kg/day; maximum, 500 mg/day) or ceftriaxone (75 mg/kg/day; maximum, 2.5 g/day), to assess the efficacy of the agents for the treatment of uncomplicated typhoid fever. Salmonella typhi was isolated from the initial cultures of blood samples from 64 patients. A total of 31 (91%) of the 34 patients treated with azithromycin and 29 (97%) of the 30 patients treated with ceftriaxone were cured (P>.05). All 64 isolates were susceptible to azithromycin and ceftriaxone. Of the patients treated with ceftriaxone, 4 subsequently had relapse of their infection. No serious side effects occurred in any study subject. Oral azithromycin administered once daily appears to be effective for the treatment of uncomplicated typhoid fever in children. If these results are confirmed, the agent could be a convenient alternative for the treatment of typhoid fever, especially in individuals in developing countries where medical resources are scarce.
Related Concept Videos
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents
Tonsillitis II: Management
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
Rocky Mountain Spotted Fever
Inhibitors of Bacterial DNA Synthesis


